CRM and AstraZeneca Won the Prestigious Business Excellence Award 2024 for UK-Malaysia Partnership of the Year!

SUBANG JAYA, 22 MAY 2024 – Who knew what seeded few years back will result such triumph. To set the scene, we head back to 2022, when Malaysia is raring to expand early phase clinical trials, following the successful setup of First-in-Human (FIH) ecosystem in the country. Active efforts were made to engage with pharmaceutical organisations and biotechs to bring in early phase studies. During ESMO Congress 2022, CRM team together with Dr Voon Pei Jye of Sarawak General Hospital (SGH) had engaged with AZ international directors & what transpired then charted the course to the beginning of a partnership.

In early 2023, both CRM and AZ entered an MOU, formalising their collaboration in expanding AZ’s clinical research presence in Malaysia, including in early phase clinical research in SGH. That year saw clinical studies by AZ grew almost 3-fold in Malaysia, followed with the expansion of its clinical research operations. Fast forward to ESMO Congress 2023, CRM team along with MOH Head of Specialty in Oncology & Radiotherapy had the opportunity to connect with AZ’s leadership to explore new trial opportunities to Malaysia. What was heard then was truly a testament to Malaysia’s clinical research capabilities, as there positive resounding acknowledgement on the clinical trial delivery by team Malaysia in AZ’s global trials, especially in terms of speed and quality.

We are now in the first half of 2024, and the partnership delivers yet again! AZ has awarded a FIH study to SGH, for the indication of solid tumour. It is the first FIH trial in Malaysia that involves the use of a biological product. Factoring these achievements, and the astounding expansion in Malaysia, AZ was named the recipient of CRM Sponsored Research Awards 2024 for Top Sponsor of the Year.

Our sincere gratitude to our investigators & study coordinators who have worked hard in making this collaboration a success. And to AstraZeneca we look forward toward achieving more milestones together.